Perhexiline directly inhibits arterial myosin phosphorylation and stimulates cardiac myofibrillar ATPase activity.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D001011:Aorta / Q000378:metabolism; D002417:Cattle; D004285:Dogs; D004789:Enzyme Activation / Q000187:drug effects; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology*; D009218:Myosins / Q000378:metabolism*; D010480:Perhexiline / Q000494:pharmacology*; D010766:Phosphorylation
D000251:Adenosine Triphosphatases; D009218:Myosins; D010480:Perhexiline